News for Inhibitex LLC - Google Finance

Synergy On Sale: Why This Opportunity Shouldn't Be Missed

Thu, 25 Apr 2013 15:51:15 GMT

Synergy On Sale: Why This Opportunity Shouldn't Be Missed
Seeking Alpha - Apr 25, 2013

As many on Wall Street know, Board Chairman Gabriel Cerrone has a track record of ushering in high take-out premiums for development-stage biotech companies (he championed the $2.5 billion sale of Inhibitex to Bristol-Myers Squibb (BMY) in early 2012 ...

Bristol-Myers Squibb Co. Completes Acquisition Of Inhibitex, Inc.

Mon, 13 Feb 2012 22:03:00 GMT

Bristol-Myers Squibb Co. Completes Acquisition Of Inhibitex, Inc.
Reuters Key Development - Feb 13, 2012

Bristol-Myers Squibb Co. Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc.

Mon, 13 Feb 2012 12:30:00 GMT

Bristol-Myers Squibb Co. Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc.
Reuters Key Development - Feb 13, 2012

Bull & Lifshitz, LLP Announces Investigation Of Inhibitex, Inc.

Thu, 19 Jan 2012 16:28:00 GMT

Bull & Lifshitz, LLP Announces Investigation Of Inhibitex, Inc.
Reuters Key Development - Jan 19, 2012

Bristol-Myers Squibb Co. Begins Tender Offer To Acquire Inhibitex, Inc.

Fri, 13 Jan 2012 12:30:00 GMT

Bristol-Myers Squibb Co. Begins Tender Offer To Acquire Inhibitex, Inc.
Reuters Key Development - Jan 13, 2012

Potentially Unfair Tender Offer For Inhibitex, Inc. Triggers Shareholder-Claim Investigation By Securities Class Action Lawyers At Goldfarb Branham LLP

Wed, 11 Jan 2012 16:50:00 GMT

Potentially Unfair Tender Offer For Inhibitex, Inc. Triggers Shareholder-Claim Investigation By Securities Class Action Lawyers At Goldfarb Branham LLP
Reuters Key Development - Jan 11, 2012

Inhibitex, Inc. Reports Recent Clinical Trial

Tue, 29 Nov 2011 12:00:01 GMT

Inhibitex, Inc. Reports Recent Clinical Trial
Reuters Key Development - Nov 29, 2011